Navigating the New Pharmacy Benefit Landscape:
3 Critical Trends Shaping Employer Strategies
Employers face unprecedented challenges in providing affordable medication access in today’s rapidly evolving healthcare environment. PSG, an EPIC company, research unveils three critical trends that are reshaping how organizations approach pharmacy benefits.
What You’ll Discover in the Report:
- Cell and Gene Therapies
- Breakthrough treatments with life-changing potential
- Multi-million dollar price tags transforming healthcare economics
- Key Insight: 69% of employers see cell and gene therapies as a major affordability challenge
- GLP-1 Drugs for Obesity and Diabetes
- Explosive growth in diabetes and obesity treatments
- Skyrocketing interest and complex coverage decisions
- Key Insight: 75% of employers have experienced increased GLP-1 spend
- Pharmacy Benefit Disruption
- Increasing scrutiny of traditional pharmacy benefit models
- Emerging alternative solutions challenging the status quo
- Key Insight: 44% of employers are ready to embrace disruptive changes
This Matters to You
Employers are at a critical juncture. With innovative therapies, evolving medication landscapes, and mounting cost pressures, understanding these trends is crucial for strategic decision-making.
Download the full report now to learn more!
DOWNLOADABLE RESOURCES
Fill out this short form to download your report on the 3 Critical Trends Shaping Employer Strategies you need to know to navigate the new pharmacy benefit landscape.
“*” indicates required fields